Results 221 to 230 of about 53,202 (260)
Some of the next articles are maybe not open access.

Can GLP-1RAs redefine transplantation standard of care?

Trends in Pharmacological Sciences
Metabolic derangements, particularly obesity and post-transplant diabetes mellitus, remain major challenges in solid organ transplantation, contributing to graft dysfunction and increased morbidity. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as promising agents due to their glucose-lowering, weight-reducing, and cardiorenal ...
openaire   +2 more sources

Kniearthrose: Lange GLP-1RA-Therapie ist krankheitsmodifizierend

Aktuelle Rheumatologie
Eine Gewichtsreduktion gilt als eine der ersten Maßnahmen bei Kniearthrose (KOA). Jüngste Erkenntnisse deuten darauf hin, dass bei Diabetes mellitus Typ 2 empfohlene Glucagonlike-Peptid-1-Rezeptor-Agonisten (GLP-1RAs), die eine Gewichtsreduktion bewirken, eine geringe Verbesserung ...
openaire   +1 more source

Fixed-Ratio Combinations of Basal Insulin and GLP-1RA in the Management of Type 2 Diabetes Mellitus: Highlights from the Literature

Endocrine, Metabolic and Immune Disorders - Drug Targets, 2021
Vincenzo Triggiani   +2 more
exaly  

IP06-36 CHARACTERIZING KIDNEY STONE EPISODES BY GLP-1RA MEDICATION IN GLP-1RA USERS

Journal of Urology
Shreya Thiagarajan   +3 more
openaire   +1 more source

Global trends and focuses of GLP-1RA in renal disease: a bibliometric analysis and visualization from 2005 to 2022

Naunyn-Schmiedeberg's Archives of Pharmacology, 2023
Yilin Meng, Yaqing Wang
exaly  

The benefit of GLP-1RA in different age groups in the cardiovascular outcome trials

Diabetes Research and Clinical Practice, 2021
Basem Mishriky   +2 more
exaly  

SGLT2i and GLP-1RA Use in the USA

Journal of General Internal Medicine
Kyle Steiger, Rozalina G. McCoy
openaire   +1 more source

Home - About - Disclaimer - Privacy